More Zelira Therapeutics Ltd. news
Zelira Therapeutics Ltd.ASX: ZLD

Zelira Expands HOPE Distribution to Washington DC, USA

Dec 13, 2020 at 9:43 PM EST · Issued by Zelira Therapeutics Ltd.

Filed with ASX · Dec 13, 2020 at 9:43 PM EST

On 6ix: 6ix.com/news/zelira-expands-hope-distribution-to-washington-dc-usa

Zelira Therapeutics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Zelira Therapeutics Ltd. on 6ix

Story so far

  • Zelira Therapeutics expands HOPE distribution in the U.S.ADec 4, 2019

Earlier from Zelira Therapeutics

  • R&D Tax Incentive RefundDec 10, 2020
  • ZLD Partners with SprinJene to Launch CBD Toothpaste in USDec 1, 2020
  • Emyria Deal and Autism Observational Trial for HOPE ProductsNov 8, 2020
  • September 2020 Quarterly ReportOct 29, 2020
  • HOPE launches in Australia after TGA approves releaseOct 26, 2020

Later from Zelira Therapeutics

  • December 2020 Quarterly ReportJan 28, 2021
  • Strategic Transition and Executive ChangesFeb 14, 2021
  • Appendix 4D & FY21 Interim Financial ReportFeb 22, 2021
  • Zelira Announces Record Third Quarter RevenueApr 14, 2021
  • March 2021 Quarterly ReportApr 21, 2021
All Zelira Therapeutics news releases↗

Follow Zelira Therapeutics into a list and get an email when it puts out news.

Follow Zelira Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer